© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, IN8bio, Inc. (INAB) shows an Average True Range (ATR) of 0.22 and an Enterprise Value of 29.5M. Its average trading volume over the past 3 months is 259.89K, indicating liquidity. These fundamental metrics provide insight into INAB's underlying financial health and market activity.
IN8bio, Inc. (INAB) technical indicators as of January 1, 2026: the SMA 20 is 32.43%, SMA 50 at 29.55%, and SMA 200 at -19.19%. The RSI 14 value is 64.8, suggesting its current momentum. These technical analysis signals help assess INAB's price trends and potential future movements.
IN8bio, Inc. (INAB) stock performance overview as of January 1, 2026: The 52-week high is $3.66 (currently -81.33% below), and the 52-week low is $0.101 (currently 100% above). Over the past year, INAB's performance is 897.44%, compared to the S&P 500's 12.29% change.
According to market data, IN8bio, Inc. (INAB) stock's recent performance metrics show that over the last month, INAB is 18.18%, with a Year-to-Date (YTD) performance of 809.8%. Over the past year, the stock has seen a 897.44% change. These figures summarize INAB's price movements across various periods, reflecting its historical returns.
According to current financial data, INAB stock's P/E (TTM) ratio is -0.51, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for INAB, including P/S (4.25), P/B (0.80), and P/FCF (-0.73), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.